Alimera Sciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.09.24	Alimera Files Lawsuit Against ANI To Enforce Merger Deal, Stock Down Nearly 19% (RTTNews)
24.06.24	Alimera Sciences To Be Acquired By ANI Pharma For $381 Mln; Stock Up (RTTNews)
02.01.24	Alimera Sciences Names Elliot Maltz To Succeed Russell Skibsted As CFO (RTTNews)
19.05.23	Pre-market Movers: MGRM, SDA, FTCH, CWD, PHIO… (RTTNews)
06.08.20	ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov. (RTTNews)
11.06.18	The UK National Institute For Health And Care Excellence To Undertake A Partial Review Of The ILUVIEN Reimbursement Guidance Allowing Broader Availability (PR Newswire)
31.05.18	Alimera Sciences Announces the Reimbursement of ILUVIEN® in Spain (PR Newswire)
22.05.18	Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference (PR Newswire)
20.07.17	SRPT Soars On Q2 Results & Outlook, AERI's Mercury-1 Does An Encore, ALIM Abuzz (RTTNews)
02.06.17	Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences (PR Newswire)
19.04.17	Research Reports Initiation on Drug Makers Stocks -- Impax Labs, Sanofi, Heron Therapeutics, and Alimera Sciences (PR Newswire)
14.03.17	Gainers & Losers Of Mar.13: ALIM, AEMD, VSTM, ARLZ, OSIR... (RTTNews)
01.03.17	EARNINGS SUMMARY: Details of Alimera Sciences, Inc. Q4 Earnings Report (RTTNews)
30.11.16	Technical Reports on Healthcare Stocks -- Teva Pharma, Endo, Ionis Pharma, and Alimera Sciences (PR Newswire)
28.11.14	Alimera Sciences Inks Deal With Deerfield Management For $50.0 Mln Financing (RTTNews)
12.11.14	Alimera Announces Marketing Authorization For ILUVIEN In Brazil - Quick Facts (RTTNews)
29.09.14	AMBI Snapped Up, ALIM's Iluvien Gets FDA Nod, GLYC Faces Glitch In Study (RTTNews)
26.09.14	Alimera: FDA Oks Iluvien As First Long-Term Treatment For Diabetic Macular Edema (RTTNews)
01.08.14	Alimera: Iluvien Marketing Authorization In Denmark For Diabetic Macular Edema (RTTNews)
30.06.14	PSivida Says Iluvien Gets Marketing Authorizations In 10 More EU Countries (RTTNews)
30.06.14	Alimera Sciences Announces Positive Outcome Of Repeat-Use Procedure For Iluvien (RTTNews)
14.04.14	Alimera Says FDA Has Set New PDUFA Date For Iluvien - Quick Facts (RTTNews)
28.03.14	EXAS Gets FDA Panel's Thumbs Up, NRX Ropes In Partners, PRPH Breathes Easy (RTTNews)
27.03.14	Alimera Sciences Resubmits Iluvien New Drug Application To FDA - Quick Facts (RTTNews)
30.12.13	What Made These Stocks Winners In 2013? (RTTNews)
19.12.13	Pre-market Movers For Dec 19 (FB, ACN, ALIM, PSDV, GRPN, VRTX) (RTTNews)
19.12.13	ALIM, PSDV Rally After Iluvien News, GILD Lays Out Plan, REGN Gets FDA Date (RTTNews)
18.10.13	PSivida, Alimera Shares Tank As FDA Rejects Iluvien NDA - Update (RTTNews)
18.10.13	Pre-market Movers For Oct 18 (GE, GOOG, FB, ANAC, SLB, ARIA, PSDV, ALIM, HON) (RTTNews)
18.10.13	Alimera Sciences Gets Complete Response Letter For Iluvien - Quick Facts (RTTNews)
18.10.13	Alimera Sciences Receives Complete Response Letter For ILUVIEN® (PR Newswire)
02.10.13	Did You Buy These Triple Digit Gainers? (RTTNews)
01.10.13	U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema (PR Newswire)
01.10.13	U.K.'s NICE Issues Final Appraisal Determination Recommending Alimera's ILUVIEN® for Chronic Diabetic Macular Edema (PR Newswire)
20.09.13	Did You Buy These Stocks? (RTTNews)
12.08.13	Alimera Sciences Reports Second Quarter 2013 Financial Results (PR Newswire)
05.08.13	Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results (PR Newswire)
24.07.13	France's Transparency Commission Issues Positive Opinion For Reimbursement Of ILUVIEN® (PR Newswire)
28.02.12	DGAP-News: Alimera Sciences Inc (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	165.65	6.94 %	K V
Sonova Hldg	282.70	2.84 %	K V
Alcon	74.88	2.41 %	K V
Kuehne+Nagel Int	194.50	1.30 %	K V
Lonza Grp	573.60	1.27 %	K V
Nestle	86.48	-0.13 %	K V
Part Grp Hldg	1’182.50	-0.63 %	K V
Swiss Re	148.40	-0.84 %	K V
Logitech Intl	72.12	-1.74 %	K V
Swiss Life Hldg	808.20	-2.98 %	K V

Alimera Sciences Aktie VALOR 11241095 / ISIN US0162591038

Nachrichten zu Alimera Sciences Inc

Aktien Top/Flop

Meistgelesene Nachrichten